soul trial oral semaglutide cardiovascular outcomes nejm 2025 results in High-Risk Type 2 Diabetes: Benefit Confirmed in the New data from the SOUL
Description
While both tirzepatide and retatrutide aim for weight loss and metabolic health, retatrutides triple agonism sets it apart.
and increased insulin early AUC and C-peptide total and early AUCs
Elevate wellness at Level Idaho.
Is this really the holy grail of body composition?
Hydration & Wellness nurse today.
Guidance on sick day management for type 1 diabetes during intercurrent illness, covering monitoring, hydration, carbohydrate intake, insulin adjustments, and when to seek care.
